Ubs Oconnor LLC Axonics, Inc. Transaction History

Ubs Oconnor LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $117,030 - $151,087	-2,370 Reduced 4.68%	48,306 $3.01 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $145,920 - $187,530	-3,000 Reduced 5.59%	50,676 $2.84 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $2.58 Million - $3.23 Million	53,676 New	53,676 $2.71 Billion
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $135,182 - $173,063	-2,570 Reduced 4.79%	51,032 $2.78 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $1.25 Million - $1.61 Million	20,989 Added 64.36%	53,602 $0
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $905,063 - $1.48 Million	22,913 Added 236.22%	32,613 $1.85 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $424,278 - $608,772	9,700 New	9,700 $607,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.